Milnacipran for the long-term treatment of fibromyalgia syndrome

摘要

The present invention is directed to methods for providing long-term treatment of fibromyalgia syndrome (FMS) by administering a dual re-uptake inhibitor to a patient 5 with FMS. More particularly, the present invention is directed to the long-term treatment of FMS by administering a norepinephrine-serotonin inhibitor (NSRI) to a patient with FMS.